Bio-Path Holdings, Inc. (BPTH)

Every figure this model derived for BPTH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2018-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2022-12-31
cash 12,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-03-31
current assets 677,000 AssetsCurrent 2026-03-31
current liabilities 9,151,000 LiabilitiesCurrent 2026-03-31
equity -8,486,000 StockholdersEquity 2026-03-31
revenue 0 Revenues 2018-12-31
sbc 0 ShareBasedCompensation 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BPTH on one particular measure came for.

RatioValue
current ratio0.07
current ratio reported0.07
deferred revenue growth-100.0
revenue growth-100.0
revenue growth per share-100.0

What to be careful about

What this model itself distrusts about BPTH's figures. Written by the derivation as it ran, not added afterwards.